Concepedia

Francesc Mitjans

FM

Statistics

Publications

25

Citations

1.5K

H-Index

18

Active since

1995

Affiliations

Universitat de Barcelona(Current)

Merck, S.L.U. (Spain)

Leitat Technological Center

Merck KGaA, Darmstadt (Germany)

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine

Francesc Mitjans is an author at Universitat de Barcelona specializing in oncology, integrin signaling, and pharmacology.

ORCID

Publications per year

1995–2019

25

Publications

25

Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Éric Petitclerc, Staffan Strömblad, Tami Von Schalscha et al. · PubMed · 1999 · 238 citations

, , +16

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.

Francesc Mitjans, Tim Meyer, Claus Fittschen et al. · PubMed · 2000 · 171 citations

, , +14

In vivo therapy of malignant melanoma by means of antagonists of αv integrins

Francesc Mitjans, Tim Meyer, Claus Fittschen et al. · International Journal of Cancer · 2000 · 145 citations · Full text

, , +14

An anti-αv-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice

Francesc Mitjans, Diane Sander, J. Adan et al. · Journal of Cell Science · 1995 · 136 citations

, , +13

Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody

José Luís Hernández, Laura Padilla, Sheila Dakhel Plaza et al. · PLoS ONE · 2013 · 107 citations · Full text

, , +17

1–5 of 25